# Treatment of Advanced Renal Cell Carcinoma With Quinacrine

> **NCT00574483** · PHASE2 · WITHDRAWN · sponsor: **Cleveland BioLabs**

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** quinacrine

## Key facts

- **NCT ID:** NCT00574483
- **Lead sponsor:** Cleveland BioLabs
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-11
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** reevaluation of compound development
- **Last updated:** 2015-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574483, "Treatment of Advanced Renal Cell Carcinoma With Quinacrine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00574483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*